AdaptHealth Corp.（AHCO）財務資料AHCOAdaptHealth Corp.

AdaptHealth Corp. (AHCO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Insurance, accounting for 61.3% of total sales, equivalent to $453.73M. Other significant revenue streams include Government and Patient Pay. Understanding this composition is critical for investors evaluating how AHCO navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, AdaptHealth Corp. maintains a gross margin of 13.37%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.60%, while the net margin is -19.47%. These profitability ratios, combined with a Return on Equity (ROE) of -16.72%, provide a clear picture of how effectively AHCO converts its operational activities into shareholder value.

In the context of the broader market, AHCO competes directly with industry leaders such as DNA and STLN. With a market capitalization of $826.25M, it holds a leading position in the sector. When comparing efficiency, AHCO's gross margin of 13.37% stands against DNA's 91.47% and STLN's 15.70%. Such benchmarking helps identify whether AdaptHealth Corp. is trading at a premium or discount relative to its financial performance.

The company reported a gross margin of 13.37% in Q2 2026, down from 35.29% in Q4 2024, indicating deteriorating profitability. Total revenue for Q2 2026 was $740.3 million, which was below analyst expectations of $846.8 million.